סאפריס 10 מג Israel - heprea - Ministry of Health

סאפריס 10 מג

merck sharp & dohme (israel - 1996) company ltd, israel - asenapine as maleate - טבליות למתן מתחת ללשון - asenapine as maleate 10 mg - asenapine - asenapine - schizophrenia saphris is indicated for the treatment of schizophrenia in adults. the efficacy of saphris was established in two 6-week trials and one maintenance trial in adults bipolar disorder monotherapy: saphris is indicated for the acute treatment of manic or mixed episodes associated with bipolar i disorder. efficacy was established in two 3-week monotherapy trials in adults adjunctive therapy: saphris is indicated as adjunctive therapy with either lithium or valproate for the acute treatment of manic or mixed episodes associated with bipolar i disorder. efficacy was established in one 3-week adjunctive trial in adults.

פלוטין 20 Israel - heprea - Ministry of Health

פלוטין 20

teva israel ltd - fluoxetine as hydrochloride - קפסולות - fluoxetine as hydrochloride 20 mg - fluoxetine - fluoxetine - treatment of depression. obsessive-compulsive disorders (ocd). flutine is also indicated for the treatment of binge-eating and vomiting behaviors in bulimia nervosa.

אגיולקס Israel - heprea - Ministry of Health

אגיולקס

megapharm ltd - ispaghula husks; ispaghula seed; senna - גרנולות - ispaghula husks 2.2 g / 100 g; senna 6.74 - 13.15 g / 100 g; ispaghula seed 52 g / 100 g - contact laxatives - for short - term treatment of constipation.

אולנזפין טבע  5 מג Israel - heprea - Ministry of Health

אולנזפין טבע 5 מג

abic marketing ltd, israel - olanzapine - טבליות מצופות פילם - olanzapine 5 mg - olanzapine - acute and maintenance treatment of schizophrenia. olanzapine teva® is indicated for the management of the manifestations of psychotic disorders. olanzapine teva® is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.prevention of recurrence in bipolar disorder: in patients whose manic episode has responded to olanzapine treatment olanzapine teva® is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder. the combination of olanzapine teva® with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

אייבו % 2 לילדים Israel - heprea - Ministry of Health

אייבו % 2 לילדים

abic marketing ltd, israel - ibuprofen - תרחיף - ibuprofen 100 mg / 5 ml - ibuprofen

אייבו % 2 לילדים Israel - heprea - Ministry of Health

אייבו % 2 לילדים

abic marketing ltd, israel - ibuprofen - תרחיף - ibuprofen 20 mg/ml - ibuprofen

אייבו % 2 לילדים Israel - heprea - Ministry of Health

אייבו % 2 לילדים

abic marketing ltd, israel - ibuprofen - תרחיף - ibuprofen 100 mg / 5 ml - ibuprofen

סימבאלתה 30 מג Israel - heprea - Ministry of Health

סימבאלתה 30 מג

eli lilly israel ltd, israel - duloxetine as hydrochloride - duloxetine as hydrochloride 30 mg - duloxetine

סימבאלתה 60 מג Israel - heprea - Ministry of Health

סימבאלתה 60 מג

eli lilly israel ltd, israel - duloxetine as hydrochloride - duloxetine as hydrochloride 60 mg - duloxetine

פרוזק Israel - heprea - Ministry of Health

פרוזק

eli lilly israel ltd, israel - fluoxetine as hydrochloride - קפסולות - fluoxetine as hydrochloride 20 mg - fluoxetine